Sun Pharma reports Q1 FY27 financial results
Sun Pharma reports Q1 FY27 financial results. The company announced its unaudited standalone and consolidated financial results for the first quarter of FY 2026-27. Key performance metrics and revenue figures were highlighted, with net profit at ₹1,872 crore and total income at ₹6,418 crore. Results reflect steady growth in domestic and international markets.
📊 STOCKS: $SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Earnings
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.